News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,480 Results
Type
Article (44178)
Company Profile (470)
Press Release (702814)
Multimedia
Podcasts (142)
Webinars (23)
Section
Business (209511)
Career Advice (2048)
Deals (36216)
Drug Delivery (137)
Drug Development (84122)
Employer Resources (174)
FDA (16799)
Job Trends (15226)
News (354643)
Policy (33306)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2685)
Accelerated approval (50)
Adcomms (30)
Allergies (176)
Alliances (51115)
ALS (220)
Alzheimer's disease (1860)
Antibody-drug conjugate (ADC) (474)
Approvals (17143)
Artificial intelligence (696)
Autoimmune disease (301)
Automation (56)
Bankruptcy (374)
Best Places to Work (11841)
BIOSECURE Act (20)
Biosimilars (224)
Biotechnology (331)
Bladder cancer (193)
Brain cancer (75)
Breast cancer (765)
Cancer (5958)
Cardiovascular disease (489)
Career advice (1740)
Career pathing (44)
CAR-T (345)
CDC (58)
Celiac Disease (3)
Cell therapy (944)
Cervical cancer (47)
Clinical research (72719)
Collaboration (2161)
Company closure (5)
Compensation (1415)
Complete response letters (90)
COVID-19 (2804)
CRISPR (116)
C-suite (1161)
Cystic fibrosis (161)
Data (7983)
Decentralized trials (3)
Denatured (45)
Depression (174)
Dermatology (88)
Diabetes (593)
Diagnostics (6992)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (337)
Drug pricing (212)
Drug shortages (32)
Duchenne muscular dystrophy (303)
Earnings (93394)
Editorial (70)
Employer branding (21)
Employer resources (153)
Events (123283)
Executive appointments (1114)
FDA (20562)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1796)
Gene editing (254)
Generative AI (58)
Gene therapy (782)
GLP-1 (1104)
Government (4834)
Grass and pollen (6)
Guidances (409)
Healthcare (19332)
HIV (82)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (319)
Immuno-oncology (99)
Indications (192)
Infectious disease (3148)
Inflammatory bowel disease (229)
Inflation Reduction Act (17)
Influenza (139)
Intellectual property (294)
Interviews (319)
IPO (16956)
IRA (53)
Job creations (3718)
Job search strategy (1442)
JPM (67)
Kidney cancer (19)
Labor market (100)
Layoffs (597)
Leadership (41)
Legal (8032)
Liver cancer (101)
Longevity (33)
Lung cancer (781)
Lymphoma (435)
Machine learning (61)
Management (59)
Manufacturing (1066)
MASH (195)
Medical device (14081)
Medtech (14203)
Mergers & acquisitions (20503)
Metabolic disorders (1560)
mRNA (231)
Multiple sclerosis (192)
NASH (20)
Neurodegenerative disease (443)
Neuropsychiatric disorders (114)
Neuroscience (3438)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4603)
Now hiring (78)
Obesity (742)
Opinion (311)
Ovarian cancer (223)
Pain (260)
Pancreatic cancer (307)
Parkinson's disease (378)
Partnered (34)
Patents (599)
Patient recruitment (687)
Peanut (63)
People (61033)
Pharmaceutical (80)
Pharmacy benefit managers (33)
Phase 1 (22870)
Phase 2 (32097)
Phase 3 (23693)
Pipeline (8812)
Policy (332)
Postmarket research (2606)
Preclinical (9822)
Press Release (67)
Prostate cancer (309)
Psychedelics (64)
Radiopharmaceuticals (343)
Rare diseases (1145)
Real estate (6080)
Recruiting (71)
Regulatory (25930)
Reports (56)
Research institute (2512)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (26)
RSV (88)
Schizophrenia (184)
Series A (306)
Series B (226)
Service/supplier (11)
Sickle cell disease (121)
Special edition (28)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3833)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (88)
The Weekly (94)
Vaccines (1123)
Venture capital (117)
Weight loss (485)
Women's health (128)
Worklife (21)
Date
Last 7 days (868)
Last 30 days (3397)
Last 365 days (30853)
2026 (12731)
2025 (31062)
2024 (36288)
2023 (41011)
2022 (52276)
2021 (56760)
2020 (54918)
2019 (47415)
2018 (35693)
2017 (33022)
2016 (32345)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (759)
Alabama (99)
Alaska (7)
Arizona (358)
Arkansas (16)
Asia (41165)
Australia (6860)
California (13498)
Canada (3792)
China (1389)
Colorado (580)
Connecticut (598)
Delaware (406)
Europe (90596)
Florida (1995)
Georgia (431)
Hawaii (3)
Idaho (62)
Illinois (1076)
India (91)
Indiana (605)
Iowa (25)
Japan (543)
Kansas (135)
Kentucky (52)
Louisiana (41)
Maine (76)
Maryland (1614)
Massachusetts (9748)
Michigan (366)
Minnesota (730)
Mississippi (6)
Missouri (146)
Montana (35)
Nebraska (29)
Nevada (142)
New Hampshire (89)
New Jersey (3557)
New Mexico (32)
New York (3509)
North Carolina (1770)
North Dakota (10)
Northern California (6748)
Ohio (401)
Oklahoma (23)
Oregon (44)
Pennsylvania (2696)
Puerto Rico (29)
Rhode Island (51)
South America (1126)
South Carolina (85)
South Dakota (2)
Southern California (5300)
Tennessee (211)
Texas (2137)
United States (47749)
Utah (399)
Vermont (1)
Virginia (329)
Washington D.C. (81)
Washington State (1105)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
747,480 Results for "xortx therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XORTX Announces US$5 Million Public Offering
May 14, 2026
·
4 min read
Press Releases
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
·
3 min read
Press Releases
XORTX Confirms Effective Date of Share Consolidation
April 2, 2026
·
3 min read
Press Releases
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 14, 2026
·
6 min read
Press Releases
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
February 5, 2026
·
5 min read
Press Releases
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
March 18, 2026
·
9 min read
Press Releases
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
October 20, 2025
·
6 min read
Press Releases
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
January 1, 2026
·
8 min read
Press Releases
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
October 21, 2025
·
4 min read
Press Releases
XORTX Announces Closing of US$1.1 Million Registered Direct Offering
October 29, 2025
·
4 min read
1 of 74,748
Next
